methotrexate i.v. solution (Pfizer Inc)
Structured Review
Methotrexate I.V. Solution, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methotrexate+solution/methotrexate/pm34637107-44-22-25
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Successful treatment and long-term follow up of idiopathic immune-mediated polyarthritis with mycophenolate mofetil in a cat Article Snippet: Therefore, Article Title: Plasma Distribution of Methotrexate and Its Polyglutamates in Pediatric Acute Lymphoblastic Leukemia: Preliminary Insights. Article Snippet: Background and Objective High-dose methotrexate (HD-MTX) is the mainstream therapy of current acute lymphoblastic leukemia (ALL) regimens, but frequent intraand interindividual differences in the clinical response to HD-MTX lead to chemotherapeutic interruption or discontinuation.. The exact mechanism of transport across the cell membrane and the disposition of active methotrexate metabolites—methotrexate polyglutamates (MTXPGs)—are not well described in the literature.. The aim of this study was to gain more insight into the plasma distribution of methotrexate and MTXPGs in pediatric patients with ALL and to clarify the obscure pathways of MTXPGs. Article Title: Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Article Snippet: A potential link between obesity, circulating leptin levels and autoimmune disease symptoms suggests that targeting the leptin receptor (ObR) might be a viable novel strategy to combat rheumatoid arthritis (RA).. However, studies in animal models and evaluation of clinical cases did not provide clear view on leptin’s involvement in RA.. To validate ObR as RA target, we used our peptide -based ObR agonists and antagonist in different in vitro and in vivo models of the disease. Selection:Article Title: Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis. Article Snippet: .. In short, 10%, 5% or 0% increments were delivered depending on the erythema response, if any, after 48 h.11 In the selection and management of the conventional therapeutic option for psoriasis, we adopted the exclusion criteria and restrictions on use from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venereology (EADV) guidelines.1 In addition, we used the recommended screening and monitoring guidelines.1 Conventional systemic treatments for psoriasis were administered as follows: Control:Article Title: In situ Preparation of a Phospholipid Gel Co-Loaded with Methotrexate and Dexamethasone for Synergistic Rheumatoid Arthritis Treatment Article Snippet: Enzyme-linked immunosorbent assay (ELISA) kits for tumor necrosis factor (TNF)-α and interleukin (IL)-1β were obtained from FineTest (Wuhan, China). .. |

